Brazil Regulator Rejects Sputnik V Vaccine Citing Serious Quality & Safety Concerns

Russian Backers Deny Risks & Say Move Is ‘Political’

 
• By Ian Schofield

Sputnik V is the latest COVID-19 vaccine to be targeted over safety concerns, but Brazil’s Anvisa has also raised questions over quality and manufacturing standards.

Studio production of syringe, vaccine ampoule and coins, on a blue background, in Brazil
The Sputnik V coronavirus vaccine has run into problems in Brazil • Source: Alamy

More from Europe

More from Geography